Skip to main content
. 2010 Aug 31;103(7):954–960. doi: 10.1038/sj.bjc.6605856

Table 2. Treatment-related adverse events.

  320 IU m−2 (N=34)
160 IU m−2 (N=37)
Overall (N=71)
Adverse event Grade 1–2 Grade 3–4 Grade 1–2 Grade 3–4 Grade 1–2 Grade 3–4
Anaemia (%) 5.9   2.7 2.7 4.2 1.4
Hypersensitivity/rash (%) 20.6   32.4   26.8  
Pruritus (%) 17.6   13.5   15.5  
Local reaction (%) 26.7   18.9   22.5  
Fatigue (%) 5.9 2.9 10.8   8.4 1.4
Fever (%) 8.8   5.4   7.0  
Diarrhea (%) 8.8   2.7   5.6  
Hyperuricemia (%) 11.8 5.9 16.2 5.4 14.1 5.6
Hyperammonemia (%) 5.9   2.7   4.2